Agreement of Dermatopathologists in the Evaluation of Clinically Difficult Melanocytic Lesions: How Golden Is the ‘Gold Standard’?
Ralph P. Braun, Martín C. Mihm(Harvard University), Dina Gutkowicz–Krusin(STRATA Skin Sciences (United States)), Harold Rabinovitz(Pontificia Universidad Católica de Chile), Lars E. French(University of Miami), Armand B. Cognetta(Memorial Sloan Kettering Cancer Center), Isabel Kolm(University of Zurich), David Polsky(New York University), Verena Ahlgrimm‐Siess, Víctor G. Prieto(The University of Texas MD Anderson Cancer Center), Margaret Oliviero, Roy King, R Hofmann‐Wellenhof(Medical University of Graz), A.A. Marghoob(Memorial Sloan Kettering Cancer Center), Paul B. Googe
Cited by 50
Related Papers
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
|Science|1996|1.3k
Congenital Nonprogressive Hemangioma
|Archives of Dermatology|2001|320
Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment
|American Journal of Clinical Dermatology|2017|314
Dermoscopic Evaluation of Amelanotic and Hypomelanotic Melanoma
|Archives of Dermatology|2008|304